Related Experiment Video
Updated: Jun 19, 2026
10:21
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
p38 Mitogen-activated protein kinase and hematologic malignancies
Yongdong Feng1, Jianguo Wen, Chung-Che Jeff Chang
1Department of Pathology, The Methodist Hospital and The Methodist Hospital Research Institute, Houston, Texas, USA.
Archives of Pathology & Laboratory Medicine
|November 6, 2009
Summary
p38 mitogen-activated protein kinase (MAPK) signaling is complex, with different isoforms impacting hematologic malignancies. Understanding these p38 MAPK isoforms is crucial for developing targeted therapies to improve treatment outcomes.
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Hematology
Background:
- p38 mitogen-activated protein kinase (MAPK) signaling regulates diverse cellular processes including apoptosis, cell cycle, and gene expression.
- The complexity of p38 MAPK pathways is amplified by varied responses to stimuli, cell types, and distinct isoforms.
- Downstream effects of p38 MAPK activation are context-dependent, influenced by stimuli, cell type, and specific isoforms involved.
Purpose of the Study:
- To review recent advancements in understanding p38 MAPK isoforms.
- To elucidate the roles of p38 MAPK in hematologic malignancies.
- To highlight the therapeutic potential of targeting specific p38 MAPK isoforms.
Main Methods:
- Comprehensive review of published literature.
- Inclusion of findings from laboratory research.
Main Results:
- p38 MAPK activation significantly influences proliferation in hematologic malignancies, acting as either a promoter or inhibitor.
- Activated p38 MAPK contributes to chemoresistance in certain hematologic cancers.
- Recent research acknowledges the critical roles of different p38 MAPK isoforms in various cellular functions.
Conclusions:
- p38 MAPK plays a pivotal role in the progression and treatment response of hematologic malignancies.
- Recognizing the distinct functions of p38 MAPK isoforms is essential for therapeutic development.
- Targeting specific p38 MAPK isoforms offers a promising strategy to enhance treatment efficacy and minimize side effects in hematopoietic malignancies.
Related Concept Videos
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...